Antara Reliant Pharmaceuticals, Inc. - Treatment for Hypercholesterolemia and Hypertriglyceridemia

Antara is a branded generic lipid-lowering agent approved as adjunctive therapy to diet for the treatment of elevated levels of cholesterol and triglycerides.

Posted: November 2004

Antara (fenofibrate) FDA Approval History

More News Resources

Drug Status

Availability Rx Prescription only

Pregnancy Category C Risk cannot be ruled out

CSA Schedule N Not a controlled drug

Recently Approved

Vosevi Vosevi (sofosbuvir, velpatasvir and voxilaprevir or SOF / VEL / VOX) is a fixed-dose combination of a...
Nerlynx Nerlynx (neratinib) is a tyrosine kinase inhibitor for the extended adjuvant treatment of...
Tremfya Tremfya (guselkumab) is an interleukin-23 blocker indicated for the treatment of moderate-to-severe...
Endari Endari (L-glutamine) is orally-administered pharmaceutical grade L-glutamine (PGLG), an amino acid...

Available RSS Feeds

Select any link below to view the RSS feed.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated July 5th, 2017), Cerner Multum™ (updated July 13th, 2017), Wolters Kluwer™ (updated July 5th, 2017) and others. To view content sources and attributions, please refer to our editorial policy.

Antara Reliant Pharmaceuticals, Inc. - Treatment for Hypercholesterolemia and Hypertriglyceridemia

More News Resources

Drug Status

Support

About

Terms & Privacy

Antara Reliant Pharmaceuticals, Inc. - Treatment for Hypercholesterolemia and Hypertriglyceridemia

More News Resources

Drug Status

Drugs.com Mobile Apps

Support

About

Terms & Privacy

Hide